Literature DB >> 27594089

The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.

Carmen Caiazza, Massimo Mallardo1.   

Abstract

microRNAs (miRNAs) are small noncoding RNAs able to suppress gene expression by targeting messenger RNAs for translational repression or, at lesser extent, degradation. miRNAs are widely expressed in tissues and organs and play fundamental roles in controlling cell proliferation, apoptosis, differentiation, cell migration, autophagy and metabolism. Uncontrolled expression of miRNAs has been associated with cancer progression, and miRNA up- or down-regulation has been linked to oncogenic and tumor-suppressive roles in cancers such as breast cancer, colorectal cancer, lung cancer, gastric cancer and glioblastoma. Altered expression of the miRNA mir-25 has been reported in many human malignant tumors, participating in various cellular processes accordingly with its broad range of potential mRNAs target. In the present review, we briefly discuss the mechanisms underlying miR-25-mediated tumorigenesis in six different human cancers and its possible future as a potential diagnostic and prognostic parameter as well as therapeutic target in clinical applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27594089     DOI: 10.2174/2211536605666160905093429

Source DB:  PubMed          Journal:  Microrna


  13 in total

1.  [Expression of PSMA 7 and its effect on proliferation, invasion, migration and tumorigenesis of gastric cancer].

Authors:  Shujing Xia; Lili Zhang; Fenggan Cheng; Zhenqing Feng; Lungen Lu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2.

Authors:  Huimin Lu; Ling Zhang; Shan Lu; Dujiang Yang; Jun Ye; Mao Li; Weiming Hu
Journal:  Exp Ther Med       Date:  2020-03-11       Impact factor: 2.447

3.  MicroRNA-25 Protects Smooth Muscle Cells against Corticosterone-Induced Apoptosis.

Authors:  Bin Zhang; Gaoxing Zhang; Tianlu Wei; Zhen Yang; Wenfeng Tan; Ziqing Mo; Jinxue Liu; Dong Li; Yidong Wei; Lukun Zhang; Keith A Webster; Jianqin Wei
Journal:  Oxid Med Cell Longev       Date:  2019-03-12       Impact factor: 6.543

4.  Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.

Authors:  Lingling Zan; Qingfeng Chen; Lei Zhang; Xiaona Li
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

Review 5.  Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma.

Authors:  Na Li; Ying Zhu
Journal:  Therap Adv Gastroenterol       Date:  2019-01-22       Impact factor: 4.409

6.  miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.

Authors:  Tangwei Wu; Hui Hu; Tianzhu Zhang; Liyuan Jiang; Xiaoyi Li; Shuiyi Liu; Chao Zheng; Ge Yan; Weiqun Chen; Yong Ning; Yong Li; Zhongxin Lu
Journal:  Oxid Med Cell Longev       Date:  2019-06-18       Impact factor: 6.543

7.  Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients.

Authors:  Xiaobin Zhang; Yi He; Haiyong Gu; Zhichao Liu; Bin Li; Yang Yang; Jie Hao; Rong Hua
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

Review 8.  A myriad of roles of miR-25 in health and disease.

Authors:  Márta Sárközy; Zsuzsanna Kahán; Tamás Csont
Journal:  Oncotarget       Date:  2018-04-20

9.  [MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].

Authors:  Rongfeng Liu; Lingling Zhang; Zhihong Xu; Yanzhi Cui
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-03-30

10.  NEDD9 Inhibition by miR-25-5p Activation Is Critically Involved in Co-Treatment of Melatonin- and Pterostilbene-Induced Apoptosis in Colorectal Cancer Cells.

Authors:  Ji Hoon Jung; Eun Ah Shin; Ju-Ha Kim; Deok Yong Sim; Hyemin Lee; Ji Eon Park; Hyo-Jung Lee; Sung-Hoon Kim
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.